Clinical trial LUNAR
LUNAR: Pivotal, randomized, open-label study of Tumor Treating Fields(TTFields) concurrent with standard of care therapies for treatment of stage 4 non-small cell lung cancer (NSCLC) following platinum failure (avis 09/04/19)
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Medical devices
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Novocure Gmbh |
| BECT Identifier | B079201732601 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02973789 |
| Inclusion criteria | Stage IV NSCLC. Progression Under or after platinium regimen |
| Last update |